Association of Plasma PTX3 Concentration and Outcomes of STEMI

NCT03894176 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 335

Last updated 2019-03-28

No results posted yet for this study

Summary

335 of patients with STEMI treated by primary PCI were assayed for PTX3 measurement by ELISA method. The angiographic and clinical outcomes were evaluated according to the PTX3 concentration.

Conditions

  • STEMI
  • Coronary; Ischemic

Interventions

OTHER

Plasma PTX3 concentration

Long pentraxin 3, thrombus burden, final TIMI flow, ST segment resolution, STEMI, primary PCI

Sponsors & Collaborators

  • Indonesian Cardiovascular Research Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-08-02
Completion
2018-09-02

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03894176 on ClinicalTrials.gov